51 results
Page 2 of 3
S-3ASR
EX-4.1
klt07oi7w6
7 Dec 20
Automatic shelf registration
4:15pm
S-8
EX-4.3
90uyxzutv1 x12
5 Aug 20
Registration of securities for employees
12:00am
424B5
bj7mtpg bm99z
30 Jul 20
Prospectus supplement for primary offering
6:01am
8-K
EX-1.1
8y2rgcjajh ow
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
424B5
qc1dsjh4 cbpwm4y
28 Jul 20
Prospectus supplement for primary offering
4:17pm
8-K
EX-1.1
rfgx y4f3jo3dd
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-10.1
zq1icfrii815yxk dg
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
10-K
EX-10.1
8deo9d0x6m8la isp
16 Mar 20
Annual report
11:09am
10-K
ifybhsy713iz
16 Mar 20
Annual report
11:09am
DEF 14A
34i3e58d9ckksy
1 Oct 19
Definitive proxy
6:07am
8-K
EX-10.1
1hnf0
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
EX-1.1
pz97pz 7q8e351d
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
ggaul 6ipb
23 Sep 19
Arcturus Therapeutics Announces Appointment of Dr. Edward Holmes M.D. andRe-Appointment of Andy Sassine to the Board of Directors
4:34pm
8-K
EX-99.1
zmzmtk6
23 Sep 19
Arcturus Therapeutics Announces Appointment of Dr. Edward Holmes M.D. andRe-Appointment of Andy Sassine to the Board of Directors
4:34pm
8-K
EX-10.1
j0f jzo4a
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
8-K
EX-10.1
on5s7iba3
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
8-K
EX-1.1
xh7i174o cv77lxyr
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm